BioAtla, Inc.
NASDAQ:BCAB
0.4555 (USD) • At close August 29, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|
| Revenue
| 11 | 0 | 0 | 0.25 | 0.429 | 5.2 | 10.627 |
| Cost of Revenue
| 0.925 | 1.221 | 1.199 | 1.33 | 19.933 | 0.026 | 26.305 |
| Gross Profit
| 10.075 | -1.221 | -1.199 | -1.08 | -19.504 | 5.174 | -15.678 |
| Gross Profit Ratio
| 0.916 | 0 | 0 | -4.32 | -45.464 | 0.995 | -1.475 |
| Reseach & Development Expenses
| 63.095 | 103.731 | 79.347 | 58.274 | 19.933 | 25.919 | 26.305 |
| General & Administrative Expenses
| 21.848 | 25.956 | 28.793 | 38.416 | 10.595 | 7.549 | 12.556 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 21.848 | 25.956 | 28.793 | 38.416 | 10.595 | 7.549 | 12.556 |
| Other Expenses
| -0.925 | -1.221 | -1.199 | -1.33 | -19.933 | 0 | -0.005 |
| Operating Expenses
| 84.018 | 128.466 | 106.941 | 95.36 | 10.595 | 33.468 | 38.861 |
| Operating Income
| -73.943 | -129.687 | -108.14 | -96.44 | -30.099 | -28.268 | -28.234 |
| Operating Income Ratio
| -6.722 | 0 | 0 | -385.76 | -70.161 | -5.436 | -2.657 |
| Total Other Income Expenses Net
| 4.167 | 6.225 | 1.658 | 1.038 | -5.754 | -1.587 | -0.745 |
| Income Before Tax
| -69.776 | -123.462 | -106.482 | -95.402 | -35.853 | -29.855 | -28.979 |
| Income Before Tax Ratio
| -6.343 | 0 | 0 | -381.608 | -83.573 | -5.741 | -2.727 |
| Income Tax Expense
| 0 | 0 | 0 | 0 | 0 | 1.547 | 0.204 |
| Net Income
| -69.776 | -123.462 | -105.283 | -95.406 | -35.853 | -29.855 | -28.979 |
| Net Income Ratio
| -6.343 | 0 | 0 | -381.624 | -83.573 | -5.741 | -2.727 |
| EPS
| -1.44 | -2.58 | -2.74 | -2.76 | -1.06 | -0.93 | -1.34 |
| EPS Diluted
| -1.44 | -2.58 | -2.74 | -2.76 | -1.06 | -0.93 | -1.34 |
| EBITDA
| -73.018 | -122.241 | -105.283 | -94.069 | -33.456 | -27.365 | -27.236 |
| EBITDA Ratio
| -6.638 | 0 | 0 | -376.276 | -77.986 | -5.263 | -2.563 |